Evidence map›Paper›PMID 40396718›Full record

ReviewClinical microbiology reviews2025

Practical Guidance for Clinical Microbiology Laboratories: Antibody and antigen detection methods for dimorphic fungal infections.

Elitza S Theel, Julianne V Kus, Thomas E Grys, Neil M Ampel, Ilan S Schwartz, Sean X Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Genomic epidemiology ofOne health (Amsterdam, Netherlands) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elitza S TheelDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-6886-2294
Julianne V KusPublic Health Ontario, Toronto, Ontario, Canada.ORCID 0000-0001-6033-7244
Thomas E GrysDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.ORCID 0000-0002-0503-124X
Neil M AmpelDivision of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA.
Ilan S SchwartzDivision of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Sean X ZhangDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-1166-2563

Funding

Mayo Clinic
6 · The paper itself

Abstract

SUMMARYAntibody and antigen detection assays continue to play a significant role in the diagnosis of dimorphic fungal pathogens, including

Indexed as

Antibodies, FungalAntigens, FungalFungiMycosesHumansSerologic TestsAntibodies, FungalAntigens, FungalantibodyantigenBlastomycesCoccidioidesdimorphic fungiHistoplasmaParacoccidioidesserologySporothrixTalaromyces

Identifiers

PMID40396718
PMCPMC12160471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.